Last reviewed · How we verify
NCT06230874
Effectiveness of Mindfulness Protocols Among OT Students
NA trial testing HOME Protocol in Mindfulness Protocols in 50 participants. Completed in 16 April 2024.
18 March 2024
Quick facts
| Lead sponsor | Jeanne Sowers |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 31 January 2024 |
| Primary completion | 18 March 2024 |
| Estimated completion | 16 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- HOME Protocol
- Control Journaling Protocol
Conditions studied
- Mindfulness Protocols — all drugs for Mindfulness Protocols →
Sponsor
Jeanne Sowers
Who can join
18 and older, any sex, with Mindfulness Protocols. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research will study the effectiveness of mindfulness protocols for OT students to decrease stress and re-engage in meaningful occupations after becoming disengaged.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06230874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mindfulness Protocols
Currently open trials in the same condition.
- NCT07364032 — Comparison Between a Mindfulness-Based Program and Standard Therapeutic Follow-Up During Pregnancy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06230874 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jeanne Sowers
- Last refreshed: 8 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06230874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing